Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

FOR IMMEDIATE RELEASE:

FORTY FORT, PA -- Experts from the National Institutes of Health, the U.S. Centers for Disease Control, the Pennsylvania Department of Health, and universities from around the country will join Geisinger’s own experts Oct. 13 in an online seminar, “Genomics and Public Health.”

The seminar will examine ways to advance public health and disease prevention through genomic testing. This free, live-streamed, two-hour event begins at 3:30 p.m.

Among the confirmed speakers are:

  • Leslie G. Biesecker, M.D., Chief, Medical Genomics and Metabolic Genetics, National Institutes of Health
  • Muin J. Khoury, M.D., Ph.D., Director, Office of Public Health Genomics, Centers for Disease Control and Prevention
  • Karen Murphy, Ph.D, RN, Secretary of Health, Pennsylvania Department of Health.
  • Glenn E. Palomaki, Ph.D., Professor of Pathology and Laboratory Medicine, Brown University
  • Maren T. Scheuner, M.D., M.¬¬¬PH, Faculty Associate, UCLA Center for Health Policy Research

The panel will be led by Geisinger’s Executive Vice President and Chief Scientific Officer David H. Ledbetter, Ph.D., and joined by Geisinger’s Clinical Genomics Director Michael F. Murray, M.D.

Those interested in attending the forum in person at Geisinger’s Precision Health Center, 190 Welles St, Suite 128, Forty Fort, must register in advance. A reception will follow.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates $10 billion in annual revenues across 126 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,700 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $15 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram, LinkedIn and X.

Content from General Links with modal content